Mail

CRBP - Corbus Pharmaceuticals Holdings, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

7.31

-0.09 (-1.22%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	7.40
Open	7.33
Bid	0.00 x 1200
Ask	0.00 x 4000
Day's Range	7.18 - 7.40
52 Week Range	4.50 - 9.11
Volume	503,242
Avg. Volume	1,576,801

Market Cap	471.168M
Beta (3Y Monthly)	1.86
PE Ratio (TTM)	N/A
EPS (TTM)	-1.20
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	24.13

Trade prices are not sourced from all markets

All

News

Press Releases

GlobeNewswire8 days ago
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
Norwood, MA, May 15, 2019 -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company focused on treating.
GlobeNewswire9 days ago
SHAREHOLDER ALERT: CRBP FSNN MWA AAPL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, May 13, 2019 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
GlobeNewswire9 days ago
CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action
NEW YORK, May 13, 2019 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following.
ACCESSWIRE10 days ago
FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 13, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Corbus Pharmaceuticals Holdings, Inc. ("Corbus" or "the Company") (NASDAQ: CRBP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between November 14, 2016 and February 28, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 13, 2019.
GlobeNewswire10 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NIO, CRBP, ARA and NTNX
NEW YORK, May 13, 2019 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss.
ACCESSWIRE12 days ago
3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 10, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Corbus Pharmaceuticals Holdings, Inc. ("Corbus" or "the Company") (NASDAQ: CRBP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between November 14, 2016 and February 28, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 13, 2019.
GlobeNewswire12 days ago
Bronstein, Gewirtz & Grossman, LLC Class Action Update: BPI, CRBP & NIO
NEW YORK, May 10, 2019 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following.
ACCESSWIRE12 days ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CRBP, ZGNX and BSX
CEDARHURST, NY / ACCESSWIRE / May 10, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
GlobeNewswire13 days ago
DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Corbus Pharmaceuticals Holdings, Inc. (“Corbus” or “the Company”) (NASDAQ: CRBP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
ACCESSWIRE13 days ago
Bronstein, Gewirtz & Grossman, LLC Class Action: BPI, CRBP & NIO
NEW YORK, NY / ACCESSWIRE / May 10, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
ACCESSWIRE13 days ago
SHAREHOLDER ALERT: CRBP MWA BSX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / May 10, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have ...
Thomson Reuters StreetEvents13 days ago
Edited Transcript of CRBP earnings conference call or presentation 9-May-19 12:30pm GMT
Q1 2019 Corbus Pharmaceuticals Holdings Inc Earnings Call
GlobeNewswire13 days ago
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc.
Law Offices of Howard G. Smith reminds investors of the upcoming May 13, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Corbus Pharmaceuticals Holdings, Inc. (“Corbus” or the “Company”) (NASDAQ: CRBP) securities between November 14, 2016 and February 28, 2019, inclusive (the “Class Period”). Investors suffering losses on their Corbus investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
ACCESSWIRE13 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of USX, CRBP and MWA
NEW YORK, NY / ACCESSWIRE / May 9, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
GlobeNewswire13 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Corbus Pharmaceuticals Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – CRBP
If you are a shareholder who purchased Corbus securities during the class period, you have until May 13, 2019, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980.
Motley Fool13 days ago
What You Need to Know About Corbus Pharmaceuticals' Q1 Earnings Update
The clinical-stage biotech's top- and bottom-line numbers weren't the most important thing in the first quarter.
Motley Fool13 days ago
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q1 2019 Earnings Call Transcript
CRBP earnings call for the period ending March 31, 2019.
ACCESSWIRE13 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CRBP, NTNX and S
NEW YORK, NY / ACCESSWIRE / May 9, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
ACCESSWIRE14 days ago
4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 9, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Corbus Pharmaceuticals Holdings, Inc. ("Corbus" or "the Company") (NASDAQ: CRBP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between November 14, 2016 and February 28, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 13, 2019.
GlobeNewswire14 days ago
CLASS ACTION UPDATE for CRCM, CRBP, ARA and MWA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, May 09, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
Zacks14 days ago
Corbus Pharmaceuticals (CRBP) Reports Q1 Loss, Lags Revenue Estimates
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of -2250.00% and -91.01%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Associated Press14 days ago
Corbus Pharmaceuticals: 1Q Earnings Snapshot
The Norwood, Massachusetts-based company said it had a loss of 43 cents per share. The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...
GlobeNewswire14 days ago
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bridgepoint, Corbus, and NIO and Encourages Investors to Contact the Firm
NEW YORK, May 08, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Bridgepoint Education,.
ACCESSWIRE14 days ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of NIO, CRBP and ARA
CEDARHURST, NY / ACCESSWIRE / May 8, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.